Connect with us

Technology

Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of Virus in Both Cloacal and Oropharyngeal Samples

Published

on

Alveo Technologies developed this groundbreaking product in partnership with x-Ovo, Royal GD and Pharmsure; first shipments of Flockscreen to EMEA expected Q3 2024

ALAMEDA, Calif., June 27, 2024 /PRNewswire/ — Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced that rigorous development and testing has demonstrated that the Flockscreen LAMP Avian Influenza Molecular Test can accurately detect the presence of virus in both cloacal and oropharyngeal samples from poultry with comparable limit of detection, sensitivity and specificity. Alveo and their development partners performed more than 20,000 reactions on over 4000 assay cartridges during their evaluation of over 100 candidate primer sets and assay conditions, using both contrived and clinical samples. Relevant regulatory bodies have been engaged and appropriate validation and verification activities will be completed prior to shipment.

The product is available today for pre-sale in Europe and the Middle East. The company expects to begin shipping in volume in the third quarter of 2024.

The current HPAI panzootic has recently spread to cattle and at least 47 other mammalian species. Due to current disease control legislation, this has led to the destruction of more than half a billion poultry worldwide. Rapid, accurate tests are vital for early detection and containment, protection of the poultry industry, the prevention of zoonotic transmission and spillover events from one species to another, food security, the maintenance of agricultural trade, and ongoing monitoring and surveillance.

Current agricultural tests for highly pathogenic avian influenza (HPAI) all suffer from one of several significant drawbacks that make them unsuited to these use cases. Polymerase chain reaction (PCR) requires lab processing, which means it can take days to receive a result, and vaccination causes serology tests to turn positive even if the bird is not infected1. Lateral flow (also known as antigen or instant tests) lacks sensitivity and produces a significant percentage of false negative results.

Alveo’s portable and rugged molecular diagnostic platform has been designed to provide accurate, rapid test results at the point of need. It functions as a core component of a notifiable disease electronic management ecosystem that the company and its strategic partners have developed to support producers, as well as governmental bodies who are looking to expand the surveillance of important zoonotic pathogens. Two multiplexed panels enable the on-site broad detection of Avian Influenza Type A virus (targeting matrix gene) in poultry with differentiation of H5, H7, and H9 subtypes using oropharyngeal or cloacal samples. Both panels contain 7 assays, 6 of which are identical between cartridges. This configuration ensures the greatest coverage of the most clinically relevant global AI strains from the past 5-10 years, through to the current strains. The platform’s rugged design enables it to function in the field under extreme conditions, including very hot and near freezing temperatures, following a drop of one meter, and when subjected to movement and vibration, which are common challenges encountered in field settings. 

Alveo has developed assays for Flockscreen LAMP AI on its proprietary molecular platform with several partners —including x-OvO, Royal GD, and Pharmsure International Ltd. — and it will provide healthcare and government authorities with a rapid, decentralized, molecular test that eliminates the need to ship hazardous samples to a lab. Additionally, the platform has the capability to wirelessly upload time-stamped geotagged results to a common portal, providing organizations with near real-time information on the spread of the virus. The platform will provide veterinarians with intuitive, rapid, point-of-need testing. For producers, Flockscreen will empower rapid responses to reduce the disease’s spread and mitigate the impact on their business.

“The creation of a decentralized testing ecosystem that respects and expands process control by disease management authorities, combined with molecular biology levels of accuracy, could lead a paradigm shift in the way notifiable disease challenges are controlled,” said Dr. Richard Currie, President, x-OvO.

“Alveo’s molecular diagnostic platform is a groundbreaking technology that raises the bar for speed and accuracy in point-of-need diagnostic testing,” said Wim Kieftenbeld, Director Business Development at Royal GD. “Combined with our expertise in veterinary diseases and diagnostics, we’ve worked together to develop an assay that accurately and rapidly delivers results at point of need for both cloacal and oropharyngeal samples, a first for agricultural diagnostics for HPAI.”

“Our platform makes it simple to test for HPAI in poultry, and we will be the first diagnostic of its kind that can test both cloacal and oropharyngeal samples,” said Shaun Holt, CEO at Alveo. “Our rugged design enables healthcare providers, veterinarians, growers, and public health officials to obtain rapid results at point of need so they can take immediate action.”

Alveo expects first customer shipments of Flockscreen LAMP AI in EMEA to begin by Q3 2024. For more information visit: alveotechnologies.com/flockscreen

About Alveo 
Alveo is the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™. Alveo’s rugged and portable, multiplex-capable diagnostic platform employs a patented method of direct electrical sensing of nucleic acid amplification to provide affordable, rapid, and accurate results. By enabling early pathogen detection, Alveo helps manage global health, food security, and supply chain resiliency by providing actionable insights at lightspeed. Know Sooner, Act Faster™ with Alveo. For more, visit: https://www.alveotechnologies.com/.

1 Tumpey TM, Alvarez R, Swayne DE, Suarez DL. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol. 2005 Feb;43(2):676-83. doi: 10.1128/JCM.43.2.676-683.2005. PMID: 15695663; PMCID: PMC548100.

Media contact
Jeff Miller
jeff@marketstreetgrp.com
541-207-6413

View original content to download multimedia:https://www.prnewswire.com/news-releases/flockscreen-lamp-avian-influenza-test-for-poultry-first-rapid-molecular-test-to-accurately-detect-the-presence-of-virus-in-both-cloacal-and-oropharyngeal-samples-302183714.html

SOURCE Alveo Technologies

Continue Reading

Technology

Trive Capital Announces Sale of EarthLink

Published

on

By

DALLAS, Oct. 20, 2026 /PRNewswire/ — Trive Capital (“Trive”) is pleased to announce that it has closed on the sale of EarthLink, LLC (“EarthLink” or the “Company”) to a family office consortium consisting of WaveDivision Capital (“Wave”), The Pritzker Organization (“TPO”) and Stephens Capital Partners (“SCP”), in partnership with EarthLink’s management team. Headquartered in Atlanta, Georgia, EarthLink is one of the largest internet service providers in the United States, serving over 500,000 internet and managed services customers nationwide. Through partnerships with several of the nation’s largest fiber and 5G providers, EarthLink has built an asset-light, nationwide network that can offer fiber internet service to more than 68 million homes.

Since Trive’s investment in EarthLink in 2018 as part of a corporate carveout, the Company has transformed from a legacy DSL and email business in precipitous decline to an asset-light connectivity platform serving over 500,000 consumers and small businesses nationwide. The Company has grown and will continue to grow based on its expanded fiber and 5G internet solutions and commitment to customer service for consumers and small businesses.

Shravan Thadani, Partner at Trive, stated, “EarthLink has been a true partnership between management and Trive in every sense of the word. The team built a differentiated, asset-light platform that gives consumers and small businesses real choice in how they get connected, and did so while standing up every function of the platform outside of its former, public parent. We are proud to have been a part of such an iconic brand’s journey and will continue to support Wave, TPO and SCP as they work with management to accelerate growth in the coming years.”

“During our partnership with Trive, we have taken one of the most trusted brands in the internet space and turned it into a trusted option for consumers and small businesses nationwide,” commented Glenn Goad, Chief Executive Officer of EarthLink. “As internet access has become one of the most important utilities in a consumer’s life, EarthLink has a renewed focus on making it easier for our customers to access the best internet options at affordable prices. Trive was critically important through and after the carve-out, and we are excited to partner with Wave, TPO and SCP to continue to grow EarthLink alongside our trusted fiber and 5G partners. Our collective goal remains the same: to provide the right technology at the right price, supported by a world-class customer experience.”

About EarthLink

EarthLink is an internet service provider offering fiber and 5G internet solutions for homes and businesses nationwide. With a focus on dependable connectivity, flexible plans, and customer-focused service, EarthLink provides broadband options designed to meet the needs of modern households and businesses. EarthLink is headquartered in Atlanta, Georgia and serves over 500,000 customers. To learn more, visit earthlink.net.

About Trive Capital

Trive Capital is a Dallas, Texas based private equity firm with more than $8 billion of regulatory assets under management. Trive focuses on investing equity and debt in what it sees as strategically viable middle-market companies with the potential for transformational upside through operational improvement.

The Trive team is comprised of seasoned investment professionals who have been involved in over 250 middle-market transactions representing in excess of $10 billion in revenue across Trive’s targeted industry sectors and situations.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trive-capital-announces-sale-of-earthlink-302914673.html

SOURCE Trive Capital

Continue Reading

Technology

Rondo Energy and Rio Tinto Advance Australia’s Largest Thermal Energy Storage Project

Published

on

By

GLADSTONE, Australia, Oct. 20, 2026 /PRNewswire/ — Rondo Energy and Rio Tinto have started front-end engineering and design on the project for a 360 MWh storage / 30 MW discharge Rondo Heat Battery, supported by a grant from the Australian Renewable Energy Agency (ARENA).

ARENA’s funding for the project will be provided in stages, with an initial $3.6 million to complete front-end engineering and design work. Following successful completion of that study, ARENA will provide up to $38 million for deployment. ARENA has also approved up to $33.3 million in conditional contingency support, which would only be made available in defined circumstances to manage specific project risks, including cost overruns and electricity costs. 

If progressed, the project would be delivered at Rio Tinto’s Yarwun alumina refinery near Gladstone, Queensland and would be one of the first large-scale demonstrations of thermal energy storage for industrial process heat globally, and a world-first for the alumina industry.

Rondo Heat Batteries use abundant, low-cost midday electricity to charge, storing energy as high-temperature heat in refractory brick, and supplying energy as 24/7 continuous process heat to industry. Typically, the heat is delivered as steam, directly into an industrial facility’s steam network. Australia regularly has 4-6 hours of surplus solar-generated renewable electricity in the middle of the day, but industrial facilities need heat 24 hours a day, not just when the sun is shining. By charging when electricity is cheap and abundant and discharging continuously, Rondo Heat Batteries turn short periods of low-cost electricity into 24/7 delivery of low-cost steam. 

For energy-intensive industries such as alumina refining, Rondo Heat Batteries create a pathway to electrification that addresses both emissions and energy costs. Because the heat battery slots into the existing steam network, the facility’s processes run exactly as before — the only thing that changes is the energy for that heat: no longer from fossil fuels, but sourced from low cost electricity instead. The Yarwun study will assess the technical and economic viability of integrating the technology into refinery operations.

“This project shows how Australia’s abundant energy can become a competitive advantage for industry,” said Dr. Kira Rundel, Rondo’s Head of Australia. “Heat batteries allow manufacturers to use low-cost electricity to produce the reliable, round-the-clock heat their operations need. Australia’s largest heat battery will show how factories can cut emissions without increasing energy costs, helping Australian industry to increase global competitiveness and supporting local manufacturing jobs.”

Rio Tinto Pacific Operations Managing Director Armando Torres said: “Reducing emissions from alumina refining is complex, particularly when it comes to generating the high-pressure steam needed for our operations.

“This study will help us determine whether thermal energy storage can provide a technically and economically viable alternative to fossil fuels for part of Yarwun’s steam requirements.

“The best way to tackle challenges of this scale is through collaboration between industry, government, and technology partners. We welcome ARENA and Rondo’s support as we assess technologies that could help reduce our Scope 1 emissions while maintaining reliable operations at Yarwun.”

About Rondo Energy

Rondo Energy delivers firm heat and power, including combined heat and power (CHP), to heavy industry and provides power solutions and long duration storage to data centers. For industrial heat applications, Rondo Heat Batteries convert 4-6 hours of low-cost electricity into continuous 24-hour, high-temperature heat, delivered as steam or hot air up to 1,000°C. The heat delivered integrates directly with existing industrial equipment and processes, eliminating on-site emissions and running on lower cost energy. Rondo heat storage can integrate with steam turbines to deliver combined heat and power (CHP) for industry, and long duration power-to-power solutions for large energy consumers such as data centers. Built on proven refractory brick as the thermal storage medium, Rondo’s platform is engineered for multi-decade operation in the most demanding industrial environments.

Rondo Heat Batteries have been delivering firm heat and power at scale since 2023, with operational facilities serving customers in fuels and cement (including steam driving turbines for electricity) in the United States and in Asia. The next unit will come online shortly – a 100 MWh Rondo Heat Battery under construction in Europe for a chemical plant. Rondo is a global company based in California, with teams across North America, Europe, the Middle East, and Australia. Providing heat and power solutions to the alumina industry is an area of focus for the company due to the strong fit of Rondo’s technology with the heat and power needs of the alumina industry.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rondo-energy-and-rio-tinto-advance-australias-largest-thermal-energy-storage-project-302914664.html

SOURCE Rondo Energy

Continue Reading

Technology

14 Organizations Earn CHIME’s Highest Digital Health Most Wired Designation for 2026

Published

on

By

ANN ARBOR, Mich., Oct. 20, 2026 /PRNewswire/ — The College of Healthcare Information Management Executives (CHIME), the leading professional organization for digital health leaders, today announced 14 organizations have achieved Level 10 in the 2026 CHIME Digital Health Most Wired (DHMW) survey. Powered by Digital Health Analytics (DHA), the survey is CHIME’s global assessment of digital health excellence, with Level 10 as its highest designation.

Representing health systems across the U.S., this year’s Level 10 organizations demonstrated exceptional performance across the enterprise digital ecosystem, leveraging technologies, data, infrastructure, and strategic practices shaping modern care delivery. The prestigious designation recognizes organizations that have moved beyond technology implementation to integrate digital investment across clinical and operational environments, producing measurable value for their health systems, patients, and providers.

The 2026 DHMW survey maintains a rigorous scoring methodology designed to account for differences in organizational size, complexity, risk, and resources, creating an equitable measure of performance across diverse healthcare environments. The model evaluates organizations across 10 distinct segments, measuring both the foundational elements required for digital maturity and the advanced practices that demonstrate broader adoption, integration, and value.

“Healthcare is experiencing extraordinary technological acceleration, driven in large part by the rapid adoption of AI and increasingly sophisticated digital capabilities,” said Russ Branzell, President and CEO of CHIME. “As that pace intensifies, the Digital Health Most Wired Survey continues to provide a rigorous benchmark for evaluating whether technology is translating into meaningful progress. It gives leaders a data-driven view of performance, critical gaps, and opportunities for high-impact investment while setting an industry standard of excellence for responsible technology adoption. The Level 10 organizations recognized this year exemplify the leadership and innovation required to turn digital investment into measurable improvements in care delivery.”

The 2026 Digital Health Most Wired survey includes data from more than 45,000 facilities worldwide, offering a global view of technology adoption, investment and performance across healthcare organizations and the evolving role of digital health in care delivery, operations and the patient and provider experience.

Each participating organization received a customized benchmarking report through the Digital Health Analytics (DHA) portal, offering detailed insights into performance metrics across 10 key segments:

InfrastructureSecurityAdministrationSupply chainAnalytics and data managementInteroperabilityPopulation healthPatient engagementInnovationClinical quality and safety

Fourteen healthcare organizations achieved Level 10 distinction, the highest designation awarded through the 2026 CHIME Digital Health Most Wired survey. The recipients are Baptist Health System (Jacksonville, Florida); Bon Secours Mercy Health (Ohio); MetroHealth Medical Center (Ohio); MultiCare Health System (Washington); Northeast Georgia Health System (Georgia); NYU Langone Health (New York); Parkview Health (Indiana); Roper St. Francis Healthcare Services, Inc. (South Carolina); Stanford Health Care (California); UCHealth (Colorado); UNC Health (North Carolina); University Health (Texas); University of Utah Health (Utah); and UPMC (Pennsylvania).

Collectively, the 2026 Level 10 designees reflect a healthcare environment in which digital performance increasingly depends on the alignment of technology strategy, data, infrastructure, and organizational priorities with strong leadership and a sustained commitment to innovation. Their results demonstrate how leading health systems are converting digital investment into measurable gains across clinical and operational environments while establishing the foundations required to responsibly adopt emerging technologies at scale.

CHIME will formally recognize these distinguished Level 10 honorees on November 12, 2026, during the CHIME26 Fall Forum in Denver, CO, which runs from November 11-14.

For additional details on the 2026 Digital Health Most Wired survey and the complete list of all Level 7-10 award recipients, visit dhanalytics.org.

About CHIME 
The College of Healthcare Information Management Executives (CHIME) is the leading professional organization for digital health executives and leaders. CHIME provides a trusted, collaborative environment where members and partners connect, share best practices, advance professional development, and advocate for the effective use of information and technology to improve health and care in the communities they serve. For more information, please visit chimecentral.org.

About Digital Health Analytics (DHA)
Digital Health Analytics provides healthcare organizations, technology companies, and academic researchers with the data, benchmarking, and market intelligence they need to lead digital transformation — 365 days a year. Powered by the College of Healthcare Information Management Executives (CHIME), DHA helps provider organizations supercharge their digital health transformation capabilities. For more information about DHA, visit dhanalytics.org.

For media inquiries, please contact:

Calli Dretke
Executive Vice President & Chief Digital and Marketing Officer
CHIME
734.665.0000
cdretke@chimecentral.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/14-organizations-earn-chimes-highest-digital-health-most-wired-designation-for-2026-302914691.html

SOURCE College of Healthcare Information Management Executives (CHIME)

Continue Reading

Trending